DIANE BURDSAL: Open Payments
NPI 1417421470 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,986 in 159 payments from 49 companies in 2025. Trend: 2023 $2,086 · 2024 $3,585 · 2025 $3,986
Food & beverage: $3,970Education: $16
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 16 | $422 |
| Novartis Pharmaceuticals Corporation | 9 | $191 |
| Kite Pharma, Inc. | 3 | $178 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| BeOne Medicines USA, Inc. | 5 | $157 |
| Celgene Corporation | 7 | $148 |
| Genentech USA, Inc. | 6 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $124 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Sobi, Inc | 5 | $117 |
Products named: KEYTRUDA, Yescarta, BRUKINSA, REBLOZYL, LIBTAYO, Vonjo, LONSURF, Trodelvy.
Industry payments across SC — which companies pay providers there.
